PSMA-targeted CAR-T
/ Xuzhou Medical University
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 29, 2022
Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=20 | Recruiting | Sponsor: The Affiliated Hospital of Xuzhou Medical University
CAR T-Cell Therapy • New P1 trial • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1